AnalystsDouglas MiehmDouglas Miehm's Stock Forecasts
AnalystsDouglas Miehm
Analyst Ranking
Bottom 5%
#4486 out of 4670 analysts
Average Return
-13.69%
Win Rate
40%10 out of 25
Risk vs Reward
Poor
Good
Douglas Miehm's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Aurinia Pharmaceuticals IncAUPH | +59.81% | $5.15 | $8.23 | 2022-11-03 - 2023-11-03 | Buy |
Bausch & Lomb CorpBLCO | +29.12% | $15.35 | $19.82 | 2022-07-25 - 2023-07-25 | Buy |
Aurinia Pharmaceuticals IncAUPH | +25.74% | $6.72 | $8.45 | 2023-01-03 - 2024-01-03 | Buy |
Bausch & Lomb CorpBLCO | +23.74% | $13.65 | $16.89 | 2022-11-02 - 2023-11-02 | Buy |
Aurinia Pharmaceuticals IncAUPH | +17.44% | $5.85 | $6.87 | 2024-02-15 - 2024-09-09 | Buy |
Douglas Miehm Analyst Color
Get additional color on Douglas Miehm's coverage of popular stocks
Douglas Miehm's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Ligand Pharmaceuticals IncLGND | 3 | Buy | $130.00 | +26.48% | Reiterates | a month ago |
Bausch & Lomb CorpBLCO | 9 | Buy | $20.00 | +26.98% | Reiterates | a month ago |
Bausch Health Companies IncBHC | 16 | Hold | $8.50 | +37.10% | Maintains | a month ago |
Aurinia Pharmaceuticals IncAUPH | 8 | Buy | $8.00 | +16.45% | Maintains | 7 months ago |
Crh Medical CorpCRHM | 1 | Hold | N/A | N/A | Downgrades | 4 years ago |
Novadaq Technologies IncNVDQ1 | 1 | Hold | N/A | N/A | Downgrades | 7 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.